Normal genes for the cholesterol side chain cleavage enzyme, P450scc, in congenital lipoid adrenal hyperplasia.

Congenital lipoid adrenal hyperplasia is the most severe form of congenital adrenal hyperplasia. Affected individuals can synthesize no steroid hormones, and hence are all phenotypic females with a severe salt-losing syndrome that is fatal if not treated in early infancy. All previous studies have suggested that the disorder is in the cholesterol side chain cleavage enzyme (P450scc), which converts cholesterol to pregnenolone. A newborn patient was diagnosed by the lack of significant concentrations of adrenal or gonadal steroids either before or after stimulation with corticotropin (ACTH) or gonadotropin (hCG). The P450scc gene in this patient and in a previously described patient were grossly intact, as evidenced by Southern blotting patterns. Enzymatic (polymerase chain reaction) amplification and sequencing of the coding regions of their P450scc genes showed these were identical to the previously cloned human P450scc cDNA and gene sequences. Undetected compound heterozygosity was ruled out in the new patient by sequencing P450scc cDNA enzymatically amplified from gonadal RNA. Northern blots of gonadal RNA from this patient contained normal sized mRNAs for P450scc and also for adrenodoxin reductase, adrenodoxin, sterol carrier protein 2, endozepine, and GRP-78 (the precursor to steroidogenesis activator peptide). These studies show that lipoid CAH is not caused by lesions in the P450scc gene, and suggest that another unidentified factor is required for the conversion of cholesterol to pregnenolone, and is disordered in congenital lipoid adrenal hyperplasia.

[1]  W. Miller,et al.  Regional mapping of genes encoding human steroidogenic enzymes: P450scc to 15q23-q24, adrenodoxin to 11q22; adrenodoxin reductase to 17q24-q25; and P450c17 to 10q24-q25. , 1991, DNA and cell biology.

[2]  J. Lambeth,et al.  Stimulation of adrenal mitochondrial cholesterol side-chain cleavage by GTP, steroidogenesis activator polypeptide (SAP), and sterol carrier protein2. GTP and SAP act synergistically. , 1991, The Journal of biological chemistry.

[3]  H. Rennert,et al.  Cloning and expression of a cDNA encoding human sterol carrier protein 2. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[4]  H. Rennert,et al.  A cDNA encoding a rat mitochondrial cytochrome P450 catalyzing both the 26-hydroxylation of cholesterol and 25-hydroxylation of vitamin D3: gonadotropic regulation of the cognate mRNA in ovaries. , 1990, DNA and cell biology.

[5]  W. Miller,et al.  Cloning and sequence of the human adrenodoxin reductase gene. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[6]  T. Mohandas,et al.  Structure, sequence, chromosomal location, and evolution of the human ferredoxin gene family. , 1990, DNA and cell biology.

[7]  W. Miller Immunoassays for human müllerian inhibitory factor (MIF): new insights into the physiology of MIF. , 1990, The Journal of clinical endocrinology and metabolism.

[8]  A. S. Lee,et al.  The rat 78,000 dalton glucose-regulated protein (GRP78) as a precursor for the rat steroidogenesis-activator polypeptide (SAP): the SAP coding sequence is homologous with the terminal end of GRP78. , 1989, Molecular endocrinology.

[9]  W. Miller,et al.  Extraadrenal steroid 21-hydroxylation is not mediated by P450c21. , 1989, The Journal of clinical investigation.

[10]  T D Lee,et al.  Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Forest,et al.  Gene conversions and rearrangements cause discordance between inheritance of forms of 21-hydroxylase deficiency and HLA types. , 1989, The Journal of clinical endocrinology and metabolism.

[12]  W. Miller Regulation of mRNAs for human steroidogenic enzymes. , 1989, Endocrine research.

[13]  J. Cupp,et al.  Identification of free and [Fe2S2]-bound cysteine residues of adrenodoxin. , 1988, The Journal of biological chemistry.

[14]  W L Miller,et al.  Cloning and structure of the human adrenodoxin gene. , 1988, DNA.

[15]  K. Yanagibashi,et al.  The regulation of intracellular transport of cholesterol in bovine adrenal cells: purification of a novel protein. , 1988, Endocrinology.

[16]  T. Mohandas,et al.  Human adrenodoxin reductase: two mRNAs encoded by a single gene on chromosome 17cen----q25 are expressed in steroidogenic tissues. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[17]  W L Miller,et al.  Molecular biology of steroid hormone synthesis. , 1988, Endocrine reviews.

[18]  T. Mohandas,et al.  Assignment of the functional gene for human adrenodoxin to chromosome 11q13----qter and of adrenodoxin pseudogenes to chromosome 20cen----q13.1. , 1988, American journal of human genetics.

[19]  R. Voutilainen,et al.  Human adrenodoxin: cloning of three cDNAs and cycloheximide enhancement in JEG-3 cells. , 1988, The Journal of biological chemistry.

[20]  W. Miller,et al.  Molecular and Clinical Advances in Congenital Adrenal Hyperplasia , 1987 .

[21]  A. Brownie,et al.  Steroidogenesis-activator polypeptide isolated from a rat Leydig cell tumor. , 1987, Science.

[22]  T. Rose,et al.  Bovine and human cDNA sequences encoding a putative benzodiazepine receptor ligand. , 1987, DNA.

[23]  Y. Fujii‐Kuriyama,et al.  Gene structure of human cytochrome P-450(SCC), cholesterol desmolase. , 1987, Journal of biochemistry.

[24]  W L Miller,et al.  Human cholesterol side-chain cleavage enzyme, P450scc: cDNA cloning, assignment of the gene to chromosome 15, and expression in the placenta. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[25]  W. Miller,et al.  Study of cholesterol side-chain cleavage (20,22 desmolase) deficiency causing congenital lipoid adrenal hyperplasia using bovine-sequence P450scc oligodeoxyribonucleotide probes. , 1986, Endocrinology.

[26]  K. Mullis,et al.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. , 1985, Science.

[27]  W. Miller,et al.  CONGENITAL ADRENAL HYPERPLASIA DUE TO DEFICIENT CHOLESTEROL SIDE‐CHAIN CLEAVAGE ACTIVITY (20, 22‐DESMOLASE) IN A PATIENT TREATED FOR 18 YEARS , 1985, Clinical endocrinology.

[28]  E. Chen,et al.  Supercoil sequencing: a fast and simple method for sequencing plasmid DNA. , 1985, DNA.

[29]  Henry A. Erlich,et al.  Enzymatic amplification of ?-globin genomic sequences and restriction site analysis for diagnosis of , 1985 .

[30]  P. Saenger Abnormal sex differentiation. , 1984, The Journal of pediatrics.

[31]  R. Chanderbhan,et al.  Sterol carrier protein2. Identification of adrenal sterol carrier protein2 and site of action for mitochondrial cholesterol utilization. , 1983, The Journal of biological chemistry.

[32]  M. Casey,et al.  Conversion of progesterone to deoxycorticosterone in the human fetus: steroid 21-hydroxylase activity in fetal tissues. , 1983, Journal of steroid biochemistry.

[33]  A. Brownie,et al.  Cholesterol side-chain cleavage in the rat adrenal cortex: isolation of a cycloheximide-sensitive activator peptide. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Casey,et al.  Extraadrenal formation of a mineralocorticosteroid: deoxycorticosterone and deoxycorticosterone sulfate biosynthesis and metabolism. , 1982, Endocrine reviews.

[35]  R. Chanderbhan,et al.  Sterol carrier protein2. Delivery of cholesterol from adrenal lipid droplets to mitochondria for pregnenolone synthesis. , 1982, The Journal of biological chemistry.

[36]  K. Wikvall,et al.  Hydroxylations in Biosynthesis of Bile Acids , 1982 .

[37]  A. Delegeane,et al.  Highly conserved glucose-regulated protein in hamster and chicken cells: preliminary characterization of its cDNA clone. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. I. Pedersen,et al.  Properties of a reconstituted vitamin D3 25-hydroxylase from rat liver mitochondria. , 1980, The Journal of biological chemistry.

[39]  E. Simpson Cholesterol side-chain cleavage, cytochrome P450, and the control of steroidogenesis , 1979, Molecular and Cellular Endocrinology.

[40]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Koizumi Shoichi,et al.  Cholesterol side-chain cleavage enzyme activity and cytochrome P-450 content in adrenal mitochondria of a patient with congenital lipoid adrenal hyperplasia (Prader disease) , 1977 .

[42]  T. Funabashi,et al.  Cholesterol side-chain cleavage enzyme activity and cytochrome P-450 content in adrenal mitochondria of a patient with congenital lipoid adrenal hyperplasia (Prader disease). , 1977, Clinica chimica acta; international journal of clinical chemistry.

[43]  J. Kirkland,et al.  Congenital lipoid adrenal hyperplasia in an eight-year-old phenotypic female. , 1973, The Journal of clinical endocrinology and metabolism.

[44]  H. Degenhart,et al.  Evidence for deficient 20 -cholesterol-hydroxylase activity in adrenal tissue of a patient with lipoid adrenal hyperplasia. , 1972, Acta endocrinologica.

[45]  C. Migeon,et al.  Congenital adrenal hyperplasia due to a deficiency of one of the enzymes involved in the biosynthesis of pregnenolone. , 1968, The Journal of clinical endocrinology and metabolism.

[46]  A. Sandison A Form of Lipoidosis of the Adrenal Cortex in an Infant , 1955, Archives of disease in childhood.

[47]  W. Kemp The Adrenal Cortex , 1937, British medical journal.